Essity stock faces legal risk over Carefree panty liners
Published on 11/03/2026 at 17:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLegal Risk Reaches Carefree
- Los Angeles County residents accuse Carefree makers of violating California restrictions on intentionally added PFAS.
- Essity says it does not intentionally add PFAS to Carefree products and plans a vigorous response.
- The dispute adds compliance and reputation risk as Essity integrates its North American feminine-care business.
Essity faces a new legal issue in its North American feminine-care business after court documents were filed in California on October 9, 2026. Ad Hoc News reported that hundreds of Los Angeles County residents accuse the makers of Carefree panty liners of violating California restrictions on intentionally added PFAS.
Allegations Remain Unproven
The plaintiffs allege that the products were intentionally made with perfluorooctanoic acid, or PFOA, a chemical in the PFAS group. The filing cites an independent laboratory test from 2024 and claims that repeated use caused health problems. The allegations have not been established by a court.
Essity spokesperson Amy Bellcourt said Carefree stands behind its products and that the company does not intentionally add PFAS chemicals to them. She also said PFAS are not ingredients used in making Carefree products and that Essity intends to respond vigorously.
Integration Raises Compliance Focus
Essity acquired Edgewell's North American feminine-care business in February 2026, bringing Carefree and other brands into its portfolio. The litigation puts product compliance, reputation and potential legal costs in focus as the group integrates the business.
Essity stock traded at 25.60 euros on Lang & Schwarz at 17:12 CET on Tuesday, November 3, 2026. Follow the real-time quote of Essity stock.
Essity B stock facts
- Company: Essity AB
- ISIN: SE0009922164
- WKN: A2DS20
- Ticker: ESSITY-B.ST
- Home exchange: Nasdaq Stockholm
- Lang & Schwarz price: 25.60 euros at 17:12 CET on November 3, 2026
Swedish equity sentiment remains an important backdrop for investors through the OMXS30 market environment.
Further developments will depend on Essity's response, the court's handling of the claims and evidence concerning the products. More news and analyses on Essity stock.
